BeOne Medicines (ONC) Property, Plant & Equipment (Net) (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.05% |
| Dec 31, 2025 | 0.83% |
| Sep 30, 2025 | 0.76% |
| Jun 30, 2025 | 1.08% |
| Mar 31, 2025 | 1.28% |
| Dec 31, 2024 | 0.99% |
| Sep 30, 2024 | 3.06% |
| Jun 30, 2024 | 6.95% |
| Mar 31, 2024 | 7.09% |
| Dec 31, 2023 | 12.40% |
| Sep 30, 2023 | 14.16% |
| Jun 30, 2023 | 11.51% |
| Mar 31, 2023 | 302.99% |
| Dec 31, 2022 | -66.33% |
| Sep 30, 2022 | 7.71% |
| Jun 30, 2022 | 1.35% |
| Mar 31, 2022 | 6.31% |
| Dec 31, 2021 | 30.35% |
| Sep 30, 2021 | 14.08% |
| Jun 30, 2021 | 5.67% |
| Mar 31, 2021 | 4.55% |
| Dec 31, 2020 | 22.82% |
| Sep 30, 2020 | 12.83% |
| Jun 30, 2020 | 7.40% |
| Mar 31, 2020 | -0.85% |
| Dec 31, 2019 | 7.02% |
| Sep 30, 2019 | 6.50% |
| Jun 30, 2019 | 7.52% |
| Mar 31, 2019 | 25.94% |
| Dec 31, 2018 | 41.16% |
| Sep 30, 2018 | 22.93% |
| Jun 30, 2018 | 17.56% |
| Mar 31, 2018 | 23.05% |
| Dec 31, 2017 | 13.10% |
| Sep 30, 2017 | 63.82% |
| Jun 30, 2017 | 9.92% |
| Mar 31, 2017 | 18.27% |
| Dec 31, 2016 | 56.92% |
| Sep 30, 2016 | 69.75% |
| Jun 30, 2016 | 26.62% |
| Mar 31, 2016 | 16.49% |